Salvatore Thomas Butera - Jul 5, 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: CEO - Volition Veterinary
Signature: /s/ Salvatore Thomas Butera
Stock symbol: VNRX
Transactions as of: Jul 5, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/7/2023, 04:02 PM
Previous filing: Jun 6, 2023
Next filing: Aug 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Award	$0	+28.8K	+18.47%	$0.00	185K	Jul 5, 2023	Direct	F1
holding	VNRX	Common Stock						61.4K	Jul 5, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 4, 2022, the reporting person was awarded 64,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,800 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,600 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 11,200 RSUs and 24,000 RSUs subject to the award previously vested and remain subject to time-based vesting.
F2	These shares of common stock are jointly owned by the reporting person and his spouse.

Content

On October 4, 2022, the reporting person was awarded 64,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,800 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,600 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 11,200 RSUs and 24,000 RSUs subject to the award previously vested and remain subject to time-based vesting.

These shares of common stock are jointly owned by the reporting person and his spouse.